Associations of Fraction of Exhaled Nitric Oxide with Beta Agonist Use in Children with Asthma
Authors:
- 1 March 2011
- journal article
- research article
- Published by SAGE Publications in Pediatric Allergy, Immunology, and Pulmonology
- Vol. 24 (1) , 45-50
Abstract
The fraction of exhaled nitric oxide (FeNO), a measure of airway inflammation, is a potential noninvasive tool to guide asthma management in children. It remains unclear, however, if FeNO adds any information beyond clinical assessment of asthma control. We evaluated the associations of FeNO level with short acting beta agonist use and compared it with other clinical asthma assessments. We examined a prospective cohort study of 225 tobacco-smoke-exposed children aged 6–12 years with doctor-diagnosed asthma, including measures of FeNO, reported days of short acting beta agonist use, and unscheduled asthma visits. FeNO was analyzed in relation to current and future (3 months later) short acting beta agonist use. Mean FeNO at baseline, 6, and 12 months was 15.5, 15.7, and 16.8 ppb. In multivariable analyses, higher FeNO level was associated with increased short acting beta agonist use but only among children who were not on inhaled corticosteroids. Among those not on an inhaled steroid, there was a 12% increase in current and 15% increase in future days of short acting beta agonist use for every 10 ppb increase in FeNO level. FeNO levels remained associated with current short acting beta agonist use even after adjusting for unscheduled asthma visits. FeNO levels remained associated with future short acting beta agonist use even after adjusting for current short acting beta agonist use or unscheduled asthma visits. We conclude that FeNO levels are associated with short acting beta agonist use but only among children who are not on an inhaled corticosteroid.Keywords
This publication has 38 references indexed in Scilit:
- Severe Asthma in Children: Insights from the National Heart, Lung, and Blood Institute's Severe Asthma Research ProgramPediatric Allergy, Immunology, and Pulmonology, 2010
- Environmental exposures, nitric oxide synthase genes, and exhaled nitric oxide in asthmatic childrenPediatric Pulmonology, 2009
- Relationship between recent short-acting β-agonist use and subsequent asthma exacerbationsAnnals of Allergy, Asthma & Immunology, 2008
- Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trialThe Lancet, 2008
- Seasonal variation and environmental predictors of exhaled nitric oxide in children with asthmaPediatric Pulmonology, 2008
- Environmental exposures and exhaled nitric oxide in children with asthmaThe Journal of Pediatrics, 2006
- What are the best estimates of pediatric asthma control?Current Opinion in Allergy and Clinical Immunology, 2006
- What is the Concordance Between the Medical Record and Patient Self-Report as Data Sources for Ambulatory Care?Medical Care, 2006
- The Aerocrine exhaled nitric oxide monitoring system NIOX is cleared by the US Food and Drug Administration for monitoring therapy in asthmaJournal of Allergy and Clinical Immunology, 2004
- Exhaled nitric oxide correlates with airway eosinophils in childhood asthmaThorax, 2002